Selected research
Industry Research
CMC Biosafety Testing Industry Research Report 2026
Market perspective
The global CMC Biosafety Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the CMC Biosafety Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the CMC Biosafety Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the CMC Biosafety Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of CMC Biosafety Testing include WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI), Suzhou Liangchen Biotechnology, JADE Biomedical, Standard Testing Group, Sino Tech World Biologicals, Q2 Solutions and Merck, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global CMC Biosafety Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to CMC Biosafety Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
CMC Biosafety Testing Market by Company
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
Q2 Solutions
Merck
Charles River Laboratories
Sartorius
Eurofins Scientific
CAS Testing Technical Services
SGS
Samsung Biologics
NTEK
Texcell
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
CMC Biosafety Testing Segment by Type
Raw Materials
Viral Banks
Cell Banks
Others
CMC Biosafety Testing Segment by Application
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions
CMC Biosafety Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CMC Biosafety Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CMC Biosafety Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CMC Biosafety Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of CMC Biosafety Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Raw Materials
- Viral Banks
- Cell Banks
- Others
Applications
- Pharmaceutical and Biotechnology Companies
- CROs and CDMOs
- Academic and Research Institutions
Companies covered
- WuXi Biologics
- Wuhan Canvest Biotechnology
- Centre Testing International (CTI)
- Suzhou Liangchen Biotechnology
- JADE Biomedical
- Standard Testing Group
- Sino Tech World Biologicals
- Q2 Solutions
- Merck
- Charles River Laboratories
- Sartorius
- Eurofins Scientific
- CAS Testing Technical Services
- SGS
- Samsung Biologics
- NTEK
- Texcell
- Sino Biological
- Miracle Points
- Suzhou Cefety Bioscience
- Zhejiang Hengyu Biological
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 CMC Biosafety Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Raw Materials
- 2.2.3 Viral Banks
- 2.2.4 Cell Banks
- 2.2.5 Others
- 2.3 CMC Biosafety Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical and Biotechnology Companies
- 2.3.3 CROs and CDMOs
- 2.3.4 Academic and Research Institutions
- 2.4 Assumptions and Limitations
3 CMC Biosafety Testing Breakdown Data by Type
- 3.1 Global CMC Biosafety Testing Historic Market Size by Type (2021-2026)
- 3.2 Global CMC Biosafety Testing Forecasted Market Size by Type (2027-2032)
4 CMC Biosafety Testing Breakdown Data by Application
- 4.1 Global CMC Biosafety Testing Historic Market Size by Application (2021-2026)
- 4.2 Global CMC Biosafety Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global CMC Biosafety Testing Market Perspective (2021-2032)
- 5.2 Global CMC Biosafety Testing Growth Trends by Region
- 5.2.1 Global CMC Biosafety Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 CMC Biosafety Testing Historic Market Size by Region (2021-2026)
- 5.2.3 CMC Biosafety Testing Forecasted Market Size by Region (2027-2032)
- 5.3 CMC Biosafety Testing Market Dynamics
- 5.3.1 CMC Biosafety Testing Industry Trends
- 5.3.2 CMC Biosafety Testing Market Drivers
- 5.3.3 CMC Biosafety Testing Market Challenges
- 5.3.4 CMC Biosafety Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top CMC Biosafety Testing Players by Revenue
- 6.1.1 Global Top CMC Biosafety Testing Players by Revenue (2021-2026)
- 6.1.2 Global CMC Biosafety Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global CMC Biosafety Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of CMC Biosafety Testing Head Office and Area Served
- 6.4 Global CMC Biosafety Testing Players, Product Type & Application
- 6.5 Global CMC Biosafety Testing Manufacturers Established Date
- 6.6 Global CMC Biosafety Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America CMC Biosafety Testing Market Size (2021-2032)
- 7.2 North America CMC Biosafety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America CMC Biosafety Testing Market Size by Country (2021-2026)
- 7.4 North America CMC Biosafety Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe CMC Biosafety Testing Market Size (2021-2032)
- 8.2 Europe CMC Biosafety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe CMC Biosafety Testing Market Size by Country (2021-2026)
- 8.4 Europe CMC Biosafety Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific CMC Biosafety Testing Market Size (2021-2032)
- 9.2 Asia-Pacific CMC Biosafety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific CMC Biosafety Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific CMC Biosafety Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America CMC Biosafety Testing Market Size (2021-2032)
- 10.2 South America CMC Biosafety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America CMC Biosafety Testing Market Size by Country (2021-2026)
- 10.4 South America CMC Biosafety Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa CMC Biosafety Testing Market Size (2021-2032)
- 11.2 Middle East & Africa CMC Biosafety Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa CMC Biosafety Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa CMC Biosafety Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 WuXi Biologics
- 12.1.1 WuXi Biologics Company Information
- 12.1.2 WuXi Biologics Business Overview
- 12.1.3 WuXi Biologics Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.1.4 WuXi Biologics CMC Biosafety Testing Product Portfolio
- 12.1.5 WuXi Biologics Recent Developments
- 12.2 Wuhan Canvest Biotechnology
- 12.2.1 Wuhan Canvest Biotechnology Company Information
- 12.2.2 Wuhan Canvest Biotechnology Business Overview
- 12.2.3 Wuhan Canvest Biotechnology Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.2.4 Wuhan Canvest Biotechnology CMC Biosafety Testing Product Portfolio
- 12.2.5 Wuhan Canvest Biotechnology Recent Developments
- 12.3 Centre Testing International (CTI)
- 12.3.1 Centre Testing International (CTI) Company Information
- 12.3.2 Centre Testing International (CTI) Business Overview
- 12.3.3 Centre Testing International (CTI) Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.3.4 Centre Testing International (CTI) CMC Biosafety Testing Product Portfolio
- 12.3.5 Centre Testing International (CTI) Recent Developments
- 12.4 Suzhou Liangchen Biotechnology
- 12.4.1 Suzhou Liangchen Biotechnology Company Information
- 12.4.2 Suzhou Liangchen Biotechnology Business Overview
- 12.4.3 Suzhou Liangchen Biotechnology Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.4.4 Suzhou Liangchen Biotechnology CMC Biosafety Testing Product Portfolio
- 12.4.5 Suzhou Liangchen Biotechnology Recent Developments
- 12.5 JADE Biomedical
- 12.5.1 JADE Biomedical Company Information
- 12.5.2 JADE Biomedical Business Overview
- 12.5.3 JADE Biomedical Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.5.4 JADE Biomedical CMC Biosafety Testing Product Portfolio
- 12.5.5 JADE Biomedical Recent Developments
- 12.6 Standard Testing Group
- 12.6.1 Standard Testing Group Company Information
- 12.6.2 Standard Testing Group Business Overview
- 12.6.3 Standard Testing Group Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.6.4 Standard Testing Group CMC Biosafety Testing Product Portfolio
- 12.6.5 Standard Testing Group Recent Developments
- 12.7 Sino Tech World Biologicals
- 12.7.1 Sino Tech World Biologicals Company Information
- 12.7.2 Sino Tech World Biologicals Business Overview
- 12.7.3 Sino Tech World Biologicals Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.7.4 Sino Tech World Biologicals CMC Biosafety Testing Product Portfolio
- 12.7.5 Sino Tech World Biologicals Recent Developments
- 12.8 Q2 Solutions
- 12.8.1 Q2 Solutions Company Information
- 12.8.2 Q2 Solutions Business Overview
- 12.8.3 Q2 Solutions Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.8.4 Q2 Solutions CMC Biosafety Testing Product Portfolio
- 12.8.5 Q2 Solutions Recent Developments
- 12.9 Merck
- 12.9.1 Merck Company Information
- 12.9.2 Merck Business Overview
- 12.9.3 Merck Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.9.4 Merck CMC Biosafety Testing Product Portfolio
- 12.9.5 Merck Recent Developments
- 12.10 Charles River Laboratories
- 12.10.1 Charles River Laboratories Company Information
- 12.10.2 Charles River Laboratories Business Overview
- 12.10.3 Charles River Laboratories Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.10.4 Charles River Laboratories CMC Biosafety Testing Product Portfolio
- 12.10.5 Charles River Laboratories Recent Developments
- 12.11 Sartorius
- 12.11.1 Sartorius Company Information
- 12.11.2 Sartorius Business Overview
- 12.11.3 Sartorius Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.11.4 Sartorius CMC Biosafety Testing Product Portfolio
- 12.11.5 Sartorius Recent Developments
- 12.12 Eurofins Scientific
- 12.12.1 Eurofins Scientific Company Information
- 12.12.2 Eurofins Scientific Business Overview
- 12.12.3 Eurofins Scientific Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.12.4 Eurofins Scientific CMC Biosafety Testing Product Portfolio
- 12.12.5 Eurofins Scientific Recent Developments
- 12.13 CAS Testing Technical Services
- 12.13.1 CAS Testing Technical Services Company Information
- 12.13.2 CAS Testing Technical Services Business Overview
- 12.13.3 CAS Testing Technical Services Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.13.4 CAS Testing Technical Services CMC Biosafety Testing Product Portfolio
- 12.13.5 CAS Testing Technical Services Recent Developments
- 12.14 SGS
- 12.14.1 SGS Company Information
- 12.14.2 SGS Business Overview
- 12.14.3 SGS Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.14.4 SGS CMC Biosafety Testing Product Portfolio
- 12.14.5 SGS Recent Developments
- 12.15 Samsung Biologics
- 12.15.1 Samsung Biologics Company Information
- 12.15.2 Samsung Biologics Business Overview
- 12.15.3 Samsung Biologics Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.15.4 Samsung Biologics CMC Biosafety Testing Product Portfolio
- 12.15.5 Samsung Biologics Recent Developments
- 12.16 NTEK
- 12.16.1 NTEK Company Information
- 12.16.2 NTEK Business Overview
- 12.16.3 NTEK Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.16.4 NTEK CMC Biosafety Testing Product Portfolio
- 12.16.5 NTEK Recent Developments
- 12.17 Texcell
- 12.17.1 Texcell Company Information
- 12.17.2 Texcell Business Overview
- 12.17.3 Texcell Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.17.4 Texcell CMC Biosafety Testing Product Portfolio
- 12.17.5 Texcell Recent Developments
- 12.18 Sino Biological
- 12.18.1 Sino Biological Company Information
- 12.18.2 Sino Biological Business Overview
- 12.18.3 Sino Biological Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.18.4 Sino Biological CMC Biosafety Testing Product Portfolio
- 12.18.5 Sino Biological Recent Developments
- 12.19 Miracle Points
- 12.19.1 Miracle Points Company Information
- 12.19.2 Miracle Points Business Overview
- 12.19.3 Miracle Points Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.19.4 Miracle Points CMC Biosafety Testing Product Portfolio
- 12.19.5 Miracle Points Recent Developments
- 12.20 Suzhou Cefety Bioscience
- 12.20.1 Suzhou Cefety Bioscience Company Information
- 12.20.2 Suzhou Cefety Bioscience Business Overview
- 12.20.3 Suzhou Cefety Bioscience Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.20.4 Suzhou Cefety Bioscience CMC Biosafety Testing Product Portfolio
- 12.20.5 Suzhou Cefety Bioscience Recent Developments
- 12.21 Zhejiang Hengyu Biological
- 12.21.1 Zhejiang Hengyu Biological Company Information
- 12.21.2 Zhejiang Hengyu Biological Business Overview
- 12.21.3 Zhejiang Hengyu Biological Revenue in CMC Biosafety Testing Business (2021-2026)
- 12.21.4 Zhejiang Hengyu Biological CMC Biosafety Testing Product Portfolio
- 12.21.5 Zhejiang Hengyu Biological Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst